#385 Alpha Score 70.6

Matt Orton

Chief Market Strategist, Raymond James
· tracked since Mar 2026
385
BUZZBERG The leaderboard is ranked by Alpha Score, which weighs a speaker's average return, their number of calls, and reputation — a credibility rating of the source that can only raise a score, never lower it. Read the FAQ
Alpha Score 70.6
Calls
12
Win Rate
58.3%
return
+6.9%
Calls 12 4 Posts tracked · 0.0/day
Calls
7d 0
30d 7
90d 9
Best Calls
XLK Long +34.4%
TSM Long +23.5%
IBB Long +11.4%
Worst Calls
KBE Long -1.8%
XBI Long -1.4%
XLV Long -0.8%
Most Mentioned
XLI ×2
XLK ×2
TSM ×2
Recent Calls
SPY Long 1 week ago
SMH Long 1 week ago
MU Long 1 week ago
Win Rate 58% Long 12 Short 0
Win Rate
7d 58%
30d 100%
90d 100%
Average Return +6.9% Long Return +6.9% Short Return -
Average Return
7d +0.9%
30d +5.9%
90d +24.3%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 21
$56.13
+3.5%
Financials have more room to run.
Financials are experiencing positive earnings momentum that is finally being rewarded in share prices, and there is more room for upside as the sector continues to deliver growth.
Thematic ETFs
Long
Mar 17
$346.38
+23.5%
Speaker explicitly names TSM as one of his favorite names, down over 10% from all-time highs, and states it will benefit from industry trends discussed at GTC. As a leading semiconductor company, TSM is positioned to capture growth from increased investments in AI and technology infrastructure. Attractive valuation after pullback combined with strong secular demand drivers support a long view. Geopolitical tensions or a slowdown in global tech capex spending could hinder performance.
Speaker explicitly names TSM as one of his favorite names, down over 10% from all-time highs, and states it will benefit from industry trends discussed at GTC. As a leading semiconductor company, TSM is positioned to capture growth from increased investments in AI and technology infrastructure. Attractive valuation after pullback combined with strong secular demand drivers support a long view. Geopolitical tensions or a slowdown in global tech capex spending could hinder performance.
Foundry Equipment
Long
Mar 17
$165.66
+5.8%
Speaker says industrials "benefit significantly from this big capex supercycle," liking electrical equipment companies and early site developers for data centers. These companies are direct beneficiaries of increased infrastructure and data center investment, driving earnings growth. Exposure to capex trends makes this sector attractive for investment, while avoiding early-cycle cyclicals hurt by energy prices. Higher energy prices in the short term could impact some cyclical components of the sector.
Speaker says industrials "benefit significantly from this big capex supercycle," liking electrical equipment companies and early site developers for data centers. These companies are direct beneficiaries of increased infrastructure and data center investment, driving earnings growth. Exposure to capex trends makes this sector attractive for investment, while avoiding early-cycle cyclicals hurt by energy prices. Higher energy prices in the short term could impact some cyclical components of the sector.
Thematic ETFs
Long
Mar 17
$139.49
+34.4%
Speaker states "tech is still a place to be," specifically citing semiconductors, memory, and optical names that will require big investments. These segments are central to the AI and data center capex supercycle, offering durable growth less disrupted by near-term uncertainty. The sector has strong growth potential, but selectivity is required to focus on beneficiaries of secular trends. Not all tech companies will benefit equally; poor stock selection could lead to underperformance.
Speaker states "tech is still a place to be," specifically citing semiconductors, memory, and optical names that will require big investments. These segments are central to the AI and data center capex supercycle, offering durable growth less disrupted by near-term uncertainty. The sector has strong growth potential, but selectivity is required to focus on beneficiaries of secular trends. Not all tech companies will benefit equally; poor stock selection could lead to underperformance.
Thematic ETFs
Long
Aug 28
$935.47
+8.4%
Buy AI supply-chain and memory pullbacks.
AI memory names and supply-chain components failed to rally after Nvidia's blowout earnings partly on tariff uncertainty, creating long-term buying opportunities after 35-50% drawdowns; upcoming Micron earnings could be a positive binary event.
AI Memory
Long
Aug 28
$562.47
+0.7%
Buy AI supply-chain and memory pullbacks.
AI memory names and supply-chain components failed to rally after Nvidia's blowout earnings partly on tariff uncertainty, creating long-term buying opportunities after 35-50% drawdowns; upcoming Micron earnings could be a positive binary event.
Thematic ETFs
Long
Aug 28
$773.65
-0.5%
Buy equity volatility on solid fundamentals.
Warsh-driven volatility is a good buying opportunity because U.S. economic fundamentals remain solid, earnings season was strong, and there are broad opportunities across the equity market.
Equity Indexes
Long
Aug 19
$70.60
-1.8%
Financials rotation has durability.
The market rotation into financials has sustainability because there has been very strong growth across banks, particularly capital markets companies, with durability at a global level.
Thematic ETFs
Long
Aug 19
$235.85
-0.1%
Welltower is healthcare REIT ballast.
Welltower is a healthcare REIT that complements information technology exposure because it is levered to the growing U.S. aging demographic and is improving margins through smart acquisitions, shedding medical office space and focusing on full-service vertically integrated senior housing.
REITs
Long
Aug 19
$164.26
-1.4%
Select pharma, biotech, healthcare REITs.
Healthcare overall had negative earnings growth and requires selectivity; within it, pharmaceuticals, biotechnology and healthcare REITs are areas that make sense.
Thematic ETFs
Long
Aug 19
$172.32
-0.8%
Select pharma, biotech, healthcare REITs.
Healthcare overall had negative earnings growth and requires selectivity; within it, pharmaceuticals, biotechnology and healthcare REITs are areas that make sense.
Thematic ETFs
Long
Jul 21
$189.31
+11.4%
Biotech has sustainability and upside opportunity.
Biotech has been an underrepresented story with sustainable tailwinds: large pharma companies facing patent cliffs will acquire smaller biotech firms, and pullbacks provide opportunistic entry points, especially if rates stabilize or decline.
Thematic ETFs
Showing 12 of 12 calls · sorted by mentions

Matt Orton has 12 trade ideas tracked on Buzzberg across 12 tickers since March 2026. Ranked #385 on the Buzzberg Alpha leaderboard. Most covered: XLI, XLK, TSM.